Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Specker

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Zeitschrift Fur Rheumatologie|November 20, 2020
[Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatology. German version]H-M Lorenz, M Aringer, J Braun, et al.
Zeitschrift Fur Rheumatologie|April 29, 2020
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]H Schulze-Koops, J Holle, F Moosig, et al.
Zeitschrift Fur Rheumatologie|May 20, 2016
[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)]G Riemekasten, M Aringer, C G O Baerwald, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 31, 2019
[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany]K Benesova, H-M Lorenz, V Lion, et al.
Rheumatology (Oxford, England)|March 11, 2021
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in GermanyR Hasseli, U Müller-Ladner, F Keil, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|May 4, 2016
[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"]J Braun, A Krause, M Aringer, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Zeitschrift Fur Rheumatologie|November 20, 2020
[Mission statement from rheumatologists in the German Society of Rheumatology (DGRh e. V.) : We live rheumatology. German version]H-M Lorenz, M Aringer, J Braun, et al.
Zeitschrift Fur Rheumatologie|April 29, 2020
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]H Schulze-Koops, J Holle, F Moosig, et al.
Zeitschrift Fur Rheumatologie|May 20, 2016
[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)]G Riemekasten, M Aringer, C G O Baerwald, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 31, 2019
[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany]K Benesova, H-M Lorenz, V Lion, et al.
Rheumatology (Oxford, England)|March 11, 2021
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in GermanyR Hasseli, U Müller-Ladner, F Keil, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|May 4, 2016
[Standards of care for people with rheumatoid arthritis in Europe : Translation and comments of the eumusc.net recommendations supported by EULAR performed by a national task force of the professional organisations DGRh and VRA supported by "Deutsche Rheumaliga"]J Braun, A Krause, M Aringer, et al.
Pageof 8